KMTS
Price
$24.76
Change
-$1.23 (-4.73%)
Updated
Jul 13 closing price
Capitalization
1.45B
Earnings call today
Intraday BUY SELL Signals
XRAY
Price
$12.78
Change
+$0.52 (+4.24%)
Updated
Jul 13 closing price
Capitalization
2.56B
16 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KMTS vs XRAY

KMTS vs XRAY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
KMTS vs. XRAY commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KMTS is a Hold and XRAY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (KMTS: $24.76 vs. XRAY: $12.78)
Brand notoriety: KMTS and XRAY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: KMTS: 58% vs. XRAY: 60%
Market capitalization -- KMTS: $1.45B vs. XRAY: $2.56B
KMTS [@Pharmaceuticals: Other] is valued at $1.45B. XRAY’s [@Pharmaceuticals: Other] market capitalization is $2.56B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $144.19B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $7.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KMTS’s FA Score shows that 0 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • KMTS’s FA Score: 0 green, 5 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, both KMTS and XRAY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KMTS’s TA Score shows that 5 TA indicator(s) are bullish while XRAY’s TA Score has 5 bullish TA indicator(s).

  • KMTS’s TA Score: 5 bullish, 5 bearish.
  • XRAY’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, XRAY is a better buy in the short-term than KMTS.

Price Growth

KMTS (@Pharmaceuticals: Other) experienced а -11.19% price change this week, while XRAY (@Pharmaceuticals: Other) price change was +3.73% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.39%. For the same industry, the average monthly price growth was +7.29%, and the average quarterly price growth was -8.66%.

Reported Earning Dates

KMTS is expected to report earnings on Jul 14, 2026.

XRAY is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-2.39% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XRAY($2.56B) has a higher market cap than KMTS($1.45B). XRAY YTD gains are higher at: 11.811 vs. KMTS (-6.637). XRAY (-127M) and KMTS (-128M) have comparable annual earnings (EBITDA) . KMTS has more cash in the bank: 291M vs. XRAY (190M). KMTS has less debt than XRAY: KMTS (46.5M) vs XRAY (2.33B). XRAY has higher revenues than KMTS: XRAY (3.68B) vs KMTS (83.7M).
KMTSXRAYKMTS / XRAY
Capitalization1.45B2.56B56%
EBITDA-128M-127M101%
Gain YTD-6.63711.811-56%
P/E RatioN/AN/A-
Revenue83.7M3.68B2%
Total Cash291M190M153%
Total Debt46.5M2.33B2%
FUNDAMENTALS RATINGS
XRAY: Fundamental Ratings
XRAY
OUTLOOK RATING
1..100
40
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
17

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KMTSXRAY
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
56%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
59%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
60%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 1 day ago
55%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
50%
View a ticker or compare two or three
Interact to see
Advertisement
KMTS
Daily Signal:
Gain/Loss:
XRAY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ICPY12.610.04
+0.32%
Tweedy, Browne International Ins+Val ETF
MGMT50.240.09
+0.18%
Ballast Small/Mid Cap ETF
RINF32.420.06
+0.17%
ProShares Inflation Expectations
GKAT44.07N/A
N/A
Scharf Global Opportunity ETF
EWS31.43-0.21
-0.66%
iShares MSCI Singapore ETF

KMTS and

Correlation & Price change

A.I.dvisor tells us that KMTS and XRAY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KMTS and XRAY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMTS
1D Price
Change %
KMTS100%
-4.73%
XRAY - KMTS
31%
Poorly correlated
+4.24%
MMSI - KMTS
29%
Poorly correlated
-0.25%
ICUI - KMTS
27%
Poorly correlated
+2.06%
PLSE - KMTS
27%
Poorly correlated
-1.52%
NVST - KMTS
27%
Poorly correlated
+1.20%
More

XRAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, XRAY has been loosely correlated with NVST. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if XRAY jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRAY
1D Price
Change %
XRAY100%
+4.24%
NVST - XRAY
62%
Loosely correlated
+1.20%
ALGN - XRAY
52%
Loosely correlated
+0.64%
QDEL - XRAY
50%
Loosely correlated
-2.08%
KIDS - XRAY
48%
Loosely correlated
+1.92%
BAX - XRAY
47%
Loosely correlated
-0.22%
More